Experience with inhaled iloprost and bosentan in portopulmonary hypertension

A model to predict survival in patients with end-stage liver disease

2001 • 4,580 citations

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension

1993 • 1,829 citations

Inhaled Iloprost for Severe Pulmonary Hypertension

2002 • 1,760 citations

MELD and PELD: Application of survival models to liver allocation

2001 • 854 citations

Pulmonary-Hepatic vascular Disorders (PHD)

2004 • 772 citations

Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

2006 • 622 citations

Portopulmonary hypertension and hepatopulmonary syndrome

2004 • 488 citations

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

2005 • 472 citations

Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension

2001 • 394 citations

Pulmonary vascular disorders in portal hypertension

1998 • 360 citations

Association between primary pulmonary hypertension and portal hypertension: Analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations

1991 • 305 citations

Results of European post-marketing surveillance of bosentan in pulmonary hypertension

2007 • 297 citations

Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension

2004 • 260 citations

Selective Upregulation of Endothelin B Receptor Gene Expression in Severe Pulmonary Hypertension

2002 • 224 citations

Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series

1999 • 219 citations

Sildenafil treatment for portopulmonary hypertension

2006 • 212 citations

Bosentan therapy for portopulmonary hypertension

2005 • 200 citations

Portopulmonary hypertension in decompensated cirrhosis with refractory ascites

2003 • 182 citations

Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension

2005 • 164 citations

Endothelin-receptor antagonist treatment of portopulmonary hypertension

2004 • 54 citations

Endothelin and endothelin receptor antagonism in portopulmonary hypertension

2006 • 39 citations

Portopulmonary hypertension

2006 • 30 citations

Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C

2006 • 28 citations

Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis

2004 • 25 citations

Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency

2006 • 24 citations

Successful treatment of portopulmonary hypertension with bosentan: case report

2006 • 17 citations

Does lipoprotein(a) predict risk in type 2 diabetes?

2006 • 3 citations